International study supports dupilumab for treatment of moderate-to-severe asthma in children — ScienceDaily
A new medication has been added to the treatment options for children with moderate-to-severe asthma. In a late-stage clinical trial, the biologic agent dupilumab reduced the rate of severe asthma…
